The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1038/s41467-018-07016-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response
- (2017) Qiang Wang et al. PLoS Pathogens
- Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling
- (2016) Christoph H. Emmerich et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
- (2016) Paul R. Elliott et al. MOLECULAR CELL
- NOD1 and NOD2 signalling links ER stress with inflammation
- (2016) A. Marijke Keestra-Gounder et al. NATURE
- The increasing complexity of the ubiquitin code
- (2016) Richard Yau et al. NATURE CELL BIOLOGY
- SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
- (2016) Sebastian Kupka et al. Cell Reports
- CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling
- (2016) Matous Hrdinka et al. Cell Reports
- Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 Complexes
- (2015) Swarupa Panda et al. IMMUNITY
- Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response
- (2015) Andrew E.H. Elia et al. MOLECULAR CELL
- Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest)
- (2015) Manuela K Hospenthal et al. Nature Protocols
- LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes
- (2015) Peter Draber et al. Cell Reports
- RNF168 Promotes Noncanonical K27 Ubiquitination to Signal DNA Damage
- (2015) Marco Gatti et al. Cell Reports
- Gliotoxin Suppresses NF-κB Activation by Selectively Inhibiting Linear Ubiquitin Chain Assembly Complex (LUBAC)
- (2014) Hiroki Sakamoto et al. ACS Chemical Biology
- The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 Kinase by Modifying the Adaptor STING
- (2014) Qiang Wang et al. IMMUNITY
- NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
- (2014) Roberta Caruso et al. IMMUNITY
- Quantitative Proteomics Reveal a Feedforward Mechanism for Mitochondrial PARKIN Translocation and Ubiquitin Chain Synthesis
- (2014) Alban Ordureau et al. MOLECULAR CELL
- Binding of OTULIN to the PUB Domain of HOIP Controls NF-κB Signaling
- (2014) Veronique Schaeffer et al. MOLECULAR CELL
- Molecular Basis and Regulation of OTULIN-LUBAC Interaction
- (2014) Paul R. Elliott et al. MOLECULAR CELL
- Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO
- (2014) Juan Liu et al. NATURE IMMUNOLOGY
- OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin
- (2013) Kirstin Keusekotten et al. CELL
- OTULIN Restricts Met1-Linked Ubiquitination to Control Innate Immune Signaling
- (2013) Berthe Katrine Fiil et al. MOLECULAR CELL
- The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis
- (2013) Elena Rivkin et al. NATURE
- Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis
- (2013) Shuo Yang et al. NATURE IMMUNOLOGY
- Receptor interacting protein kinase 2–mediated mitophagy regulates inflammasome activation during virus infection
- (2013) Christopher Lupfer et al. NATURE IMMUNOLOGY
- A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7
- (2012) Kelly Verhelst et al. EMBO JOURNAL
- The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity
- (2012) Rune Busk Damgaard et al. MOLECULAR CELL
- TRIM27 Negatively Regulates NOD2 by Ubiquitination and Proteasomal Degradation
- (2012) Birte Zurek et al. PLoS One
- Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology
- (2011) Anton G. Kutikhin HUMAN IMMUNOLOGY
- Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1
- (2011) Xiao-Xia Jiang et al. IMMUNITY
- Linear ubiquitination prevents inflammation and regulates immune signalling
- (2011) Björn Gerlach et al. NATURE
- An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains
- (2011) Julien D F Licchesi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
- (2009) Simin Rahighi et al. CELL
- ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to Influence Inflammatory Signaling Pathways
- (2009) MingFang Tao et al. CURRENT BIOLOGY
- Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains
- (2009) David Komander et al. EMBO REPORTS
- Cellular Inhibitors of Apoptosis cIAP1 and cIAP2 Are Required for Innate Immunity Signaling by the Pattern Recognition Receptors NOD1 and NOD2
- (2009) Mathieu J.M. Bertrand et al. IMMUNITY
- Involvement of linear polyubiquitylation of NEMO in NF-κB activation
- (2009) Fuminori Tokunaga et al. NATURE CELL BIOLOGY
- XIAP mediates NOD signaling via interaction with RIP2
- (2009) A. Krieg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered Signals
- (2008) Osamu Hitotsumatsu et al. IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started